Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings
Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于向激励对象授予2023年限制性股票激励计划预留部分限制性股票的公告 | 2024-12-04 | Chinese | |
| 第四届董事会第二十次会议决议公告 | 2024-12-04 | Chinese | |
| 第四届监事会第十七次会议决议公告 | 2024-12-04 | Chinese | |
| 关于调整2023年限制性股票激励计划授予价格的公告 | 2024-12-04 | Chinese | |
| 浙江天册律师事务所关于贝达药业股份有限公司2023年限制性股票激励计划授予价格调整及向激励对象授予预留限制性股票事项之法律意见书 | 2024-12-04 | Chinese | |
| 关于使用部分闲置募集资金暂时补充流动资金的公告 | 2024-12-04 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 37809663 | 关于向激励对象授予2023年限制性股票激励计划预留部分限制性股票的公告 | 2024-12-04 | Chinese | ||
| 37809661 | 第四届董事会第二十次会议决议公告 | 2024-12-04 | Chinese | ||
| 37809655 | 第四届监事会第十七次会议决议公告 | 2024-12-04 | Chinese | ||
| 37809645 | 关于调整2023年限制性股票激励计划授予价格的公告 | 2024-12-04 | Chinese | ||
| 37809644 | 浙江天册律师事务所关于贝达药业股份有限公司2023年限制性股票激励计划授予价格调整及向激励对象授予预留限制性股票事项之法律意见书 | 2024-12-04 | Chinese | ||
| 37809641 | 关于使用部分闲置募集资金暂时补充流动资金的公告 | 2024-12-04 | Chinese | ||
| 37809636 | 2023年限制性股票激励计划预留授予激励对象名单（预留授予日） | 2024-12-04 | Chinese | ||
| 37809633 | 关于甲磺酸贝福替尼一线治疗适应症纳入《国家医保目录》的公告 | 2024-11-28 | Chinese | ||
| 37809617 | 关于盐酸恩沙替尼胶囊临床中心通过美国FDA现场核查的公告 | 2024-11-22 | Chinese | ||
| 37809614 | 关于BPI-452080片药物临床试验申请获得受理的公告 | 2024-11-20 | Chinese | ||
| 37809612 | 关于注射用MCLA-129获得临床试验批准通知书的公告 | 2024-11-19 | Chinese | ||
| 37809609 | 关于股东股份质押变动的公告 | 2024-11-15 | Chinese | ||
| 37809601 | 关于股东股份质押变动的公告 | 2024-11-07 | Chinese | ||
| 37809598 | 关于公司及子公司为融资额度内融资提供担保的进展公告 | 2024-11-04 | Chinese | ||
| 37809597 | 关于与杭州瑞普晨创科技有限公司签署《战略合作协议》及对外投资暨关联交易的公告 | 2024-11-01 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Betta Pharmaceuticals Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55541/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55541 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55541 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55541 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55541}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Betta Pharmaceuticals Co.,Ltd (id: 55541)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.